Susquehanna International Group’s scPharmaceuticals SCPH Stock Holding History

Susquehanna International Group’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,000	Closed	-$55.2K	–	13093
2024 Q1	$55.2K	Buy	+11,000	New	+$61.6K	﹤0.01%	11526
2023 Q3	–	Sell	-30,500	Closed	-$311K	–	12865
2023 Q2	$311K	Sell	30,500 -22,300	-42%	-$233K	﹤0.01%	9361
2023 Q1	$479K	Buy	52,800 +700	+1%	+$5.13K	﹤0.01%	8674
2022 Q4	$374K	Buy	+52,100	New	+$318K	﹤0.01%	8574

Susquehanna International Group's SCPH Position: Q3 2025 in Review

Susquehanna International Group sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 138,460 shares — an estimated $709K sold.

Susquehanna International Group first reported a position in SCPH in Q4 2018 and held it in 16 quarters. The position peaked at $2.06M in Q1 2023. 109 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

Susquehanna International Group reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 138,460 scPharmaceuticals shares in Q3 2025, an estimated $709K.
Susquehanna International Group first reported a position in scPharmaceuticals in Q4 2018 and held it in 16 quarters.
Susquehanna International Group's scPharmaceuticals position peaked at $2.06M in Q1 2023.
109 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.